Literature DB >> 10187841

Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A.

S Higashi1, K Miyazaki.   

Abstract

Tissue inhibitor of metalloproteinases-2 (TIMP-2) is supposed to play a regulatory role in the cell-mediated activation of progelatinase A. To investigate the mechanism of the regulation, we prepared and characterized a chemically modified TIMP-2, and examined its effects on the activation of progelatinase A. We found that treatment of TIMP-2 with cyanate ion led to loss of inhibitory activity toward matrilysin or gelatinase A. Structural and functional analyses of the modified TIMP-2 showed that carbamylation of the alpha-amino group of the NH2-terminal Cys1 of TIMP-2 led to complete loss of the inhibitory activity. When the reactive-site modified TIMP-2 was added to culture medium of concanavalin A-stimulated HT1080 cells, the conversion of endogenous progelatinase A to the intermediate form was partially inhibited, whereas that of the intermediate form to the mature one was strongly inhibited. The reactive site-modified TIMP-2 also prevented an accumulation of active gelatinase A on the cell surface. We speculate that occupation of the hemopexin-like domain of gelatinase A by the reactive site-modified TIMP-2 makes it unable for gelatinase A to be retained on the cell surface, thus preventing the autocatalytic conversion of the intermediate form of gelatinase A to its mature form.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10187841     DOI: 10.1074/jbc.274.15.10497

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

2.  Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.

Authors:  Albert G Remacle; Sergey A Shiryaev; Ilian A Radichev; Dmitri V Rozanov; Boguslaw Stec; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.

Authors:  Piotr Mydel; Zeneng Wang; Mikael Brisslert; Annelie Hellvard; Leif E Dahlberg; Stanley L Hazen; Maria Bokarewa
Journal:  J Immunol       Date:  2010-05-19       Impact factor: 5.422

4.  Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.

Authors:  Ying Wu; Shuo Wei; Steven R Van Doren; Keith Brew
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

5.  Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.

Authors:  Kazuhiro Yamamoto; Kaoru Miyazaki; Shouichi Higashi
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

6.  Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.

Authors:  Steven R Van Doren; Shuo Wei; Guanghua Gao; Beverly B DaGue; Mark O Palmier; Harinath Bahudhanapati; Keith Brew
Journal:  Biopolymers       Date:  2008-11       Impact factor: 2.505

7.  Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).

Authors:  Shouichi Higashi; Tomokazu Hirose; Tomoka Takeuchi; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2013-02-10       Impact factor: 5.157

8.  Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.

Authors:  Haiyin Zou; Ying Wu; Keith Brew
Journal:  J Biol Chem       Date:  2016-03-31       Impact factor: 5.157

9.  Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.

Authors:  Ngee H Lim; Masahide Kashiwagi; Robert Visse; Jonathan Jones; Jan J Enghild; Keith Brew; Hideaki Nagase
Journal:  Biochem J       Date:  2010-10-01       Impact factor: 3.857

10.  TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.

Authors:  Mi-Sook Lee; Jae-In Jung; Seung-Hae Kwon; Sang-Mok Lee; Kyoji Morita; Song Her
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.